Cargando…

Societal costs of non-cardiac chest pain compared with ischemic heart disease - a longitudinal study

BACKGROUND: Non-cardiac chest pain (NCCP) is a common complaint. Our aim was to present a detailed description of the costs of patients with NCCP compared to patients with acute myocardial infarction (AMI) and Angina Pectoris (AP) from a societal perspective. METHODS: Data on healthcare utilization...

Descripción completa

Detalles Bibliográficos
Autores principales: Mourad, Ghassan, Alwin, Jenny, Strömberg, Anna, Jaarsma, Tiny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851841/
https://www.ncbi.nlm.nih.gov/pubmed/24107009
http://dx.doi.org/10.1186/1472-6963-13-403
_version_ 1782294364845768704
author Mourad, Ghassan
Alwin, Jenny
Strömberg, Anna
Jaarsma, Tiny
author_facet Mourad, Ghassan
Alwin, Jenny
Strömberg, Anna
Jaarsma, Tiny
author_sort Mourad, Ghassan
collection PubMed
description BACKGROUND: Non-cardiac chest pain (NCCP) is a common complaint. Our aim was to present a detailed description of the costs of patients with NCCP compared to patients with acute myocardial infarction (AMI) and Angina Pectoris (AP) from a societal perspective. METHODS: Data on healthcare utilization and annual societal costs, including direct healthcare costs and indirect costs due to productivity loss, were collected from different databases. The participants consisted of 199 patients from a general hospital in Sweden (99 with NCCP, 51 with AMI, 49 with AP), mean age of 67 years, 59% men. RESULTS: NCCP, AMI, and AP patients had on average 54, 50 and 65 primary care contacts and 3, 4, and 4 hospital admissions during a period of 2 years. Length of hospital stay was 6, 11 and 11 days. On average, 14%, 18%, and 25% of NCCP, AMI and AP patients were on sick-leave annually, and about 12% in each group received a disability pension. The mean annual societal costs of NCCP, AMI and AP patients were €10,068, €15,989 and €14,737. CONCLUSIONS: Although the annual societal cost of NCCP patients was lower than in AMI and AP patients, the cost was still considerable (€10,068). Taken into account the high prevalence of NCCP, the cumulative annual national cost of these patients could be more than the double of AMI and AP if all patients incurred the same costs as in this study. Targeted interventions are important in order to support patients with NCCP and minimize healthcare utilization and costs.
format Online
Article
Text
id pubmed-3851841
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38518412013-12-06 Societal costs of non-cardiac chest pain compared with ischemic heart disease - a longitudinal study Mourad, Ghassan Alwin, Jenny Strömberg, Anna Jaarsma, Tiny BMC Health Serv Res Research Article BACKGROUND: Non-cardiac chest pain (NCCP) is a common complaint. Our aim was to present a detailed description of the costs of patients with NCCP compared to patients with acute myocardial infarction (AMI) and Angina Pectoris (AP) from a societal perspective. METHODS: Data on healthcare utilization and annual societal costs, including direct healthcare costs and indirect costs due to productivity loss, were collected from different databases. The participants consisted of 199 patients from a general hospital in Sweden (99 with NCCP, 51 with AMI, 49 with AP), mean age of 67 years, 59% men. RESULTS: NCCP, AMI, and AP patients had on average 54, 50 and 65 primary care contacts and 3, 4, and 4 hospital admissions during a period of 2 years. Length of hospital stay was 6, 11 and 11 days. On average, 14%, 18%, and 25% of NCCP, AMI and AP patients were on sick-leave annually, and about 12% in each group received a disability pension. The mean annual societal costs of NCCP, AMI and AP patients were €10,068, €15,989 and €14,737. CONCLUSIONS: Although the annual societal cost of NCCP patients was lower than in AMI and AP patients, the cost was still considerable (€10,068). Taken into account the high prevalence of NCCP, the cumulative annual national cost of these patients could be more than the double of AMI and AP if all patients incurred the same costs as in this study. Targeted interventions are important in order to support patients with NCCP and minimize healthcare utilization and costs. BioMed Central 2013-10-09 /pmc/articles/PMC3851841/ /pubmed/24107009 http://dx.doi.org/10.1186/1472-6963-13-403 Text en Copyright © 2013 Mourad et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Mourad, Ghassan
Alwin, Jenny
Strömberg, Anna
Jaarsma, Tiny
Societal costs of non-cardiac chest pain compared with ischemic heart disease - a longitudinal study
title Societal costs of non-cardiac chest pain compared with ischemic heart disease - a longitudinal study
title_full Societal costs of non-cardiac chest pain compared with ischemic heart disease - a longitudinal study
title_fullStr Societal costs of non-cardiac chest pain compared with ischemic heart disease - a longitudinal study
title_full_unstemmed Societal costs of non-cardiac chest pain compared with ischemic heart disease - a longitudinal study
title_short Societal costs of non-cardiac chest pain compared with ischemic heart disease - a longitudinal study
title_sort societal costs of non-cardiac chest pain compared with ischemic heart disease - a longitudinal study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851841/
https://www.ncbi.nlm.nih.gov/pubmed/24107009
http://dx.doi.org/10.1186/1472-6963-13-403
work_keys_str_mv AT mouradghassan societalcostsofnoncardiacchestpaincomparedwithischemicheartdiseasealongitudinalstudy
AT alwinjenny societalcostsofnoncardiacchestpaincomparedwithischemicheartdiseasealongitudinalstudy
AT stromberganna societalcostsofnoncardiacchestpaincomparedwithischemicheartdiseasealongitudinalstudy
AT jaarsmatiny societalcostsofnoncardiacchestpaincomparedwithischemicheartdiseasealongitudinalstudy